While oral misoprostol isn't superior to vaginal dinoprostone for induction of labor at term, it isn't inferior either. It doesn't lead to poorer health outcomes for women or their infants and offers a preferred route of administration.
While oral misoprostol isn't superior to vaginal dinoprostone for induction of labor at term, it isn't inferior either. It doesn't lead to poorer health outcomes for women or their infants and offers a preferred route of administration.
Researchers from Australia conducted a randomized, double-blind, placebo-controlled trial involving 741 women. They found no significant differences in the rates of vaginal birth not achieved in 24 hours (46% vs. 41.2%), cesarean section (22.7% vs. 26.6%), cesarean section for fetal distress (8.8% vs. 9.3%), or in uterine hyperstimulation with changes in fetal heart rate (0.8% vs. 1.6%). In addition, the women randomized to receive misoprostol reported a more positive birth experience.
Dodd JM, Crowther CA, Robinson JS. Oral misoprostol for induction of labour at term: randomised controlled trial. BMJ. 2006;332:509-513.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More